We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
-9.03%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$203M
AUM Growth
-$62M
Cap. Flow
-$31.6M
Cap. Flow %
-15.6%
Top 10 Hldgs %
66.28%
Holding
73
New
13
Increased
6
Reduced
20
Closed
25

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$18.8M
2
NMBL
Nimble Storage, Inc.
NMBL
+$10.7M
3
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$10.1M
4
NFLX icon
Netflix
NFLX
+$5.37M
5
SAGE
Sage Therapeutics
SAGE
+$3.28M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$14.8M
2
BLUE
bluebird bio
BLUE
+$9.06M
3
AR icon
Antero Resources
AR
+$7.12M
4
HAPN
Happen Inc
HAPN
+$6.64M
5
KYNB
Kyntra Bio
KYNB
+$5.79M

Sector Composition

Rank Sector Weight
1 Communication Services 23.64%
2 Technology 22.66%
3 Healthcare 13.39%
4 Financials 10.05%
5 Industrials 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDOT icon
26
Green Dot
GDOT
$743M
$1.73M 0.85%
98,016
-25,000
-20% -$464K
GOOGL icon
27
Alphabet (Google) Class A
GOOGL
$4.27T
$1.54M 0.76%
+48,160
New +$1.55M
GOOG icon
28
Alphabet (Google) Class C
GOOG
$4.27T
$1.47M 0.72%
48,280
-89,640
-65% -$2.75M
QLYS icon
29
Qualys
QLYS
$4.94B
$1.31M 0.64%
+45,965
New +$1.54M
WAGE
30
DELISTED
WageWorks, Inc.
WAGE
$1.19M 0.59%
26,469
– –
XLRN
31
DELISTED
Acceleron Pharma
XLRN
$1.06M 0.52%
42,463
– –
PETX
32
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.03M 0.51%
+121,705
New +$2.06M
CVT
33
DELISTED
CVENT, INC.
CVT
$948K 0.47%
28,157
-2,090
-7% -$63.2K
BOX icon
34
Box
BOX
$4.33B
$904K 0.45%
+71,860
New +$1.07M
XENT
35
DELISTED
Intersect ENT, Inc
XENT
$891K 0.44%
38,086
-8,114
-18% -$224K
YDLE
36
DELISTED
YODLEE INC COMMON STOCK
YDLE
$768K 0.38%
47,628
+10,540
+28% +$158K
SEDG icon
37
SolarEdge
SEDG
$2.52B
$746K 0.37%
+32,535
New +$911K
MKTO
38
DELISTED
MARKETO INC COM STK (DE)
MKTO
$729K 0.36%
25,636
+9,104
+55% +$257K
OMED
39
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$729K 0.36%
43,965
– –
YELP icon
40
Yelp
YELP
$1.45B
$500K 0.25%
23,104
– –
JD icon
41
JD.com
JD
$44.1B
$486K 0.24%
18,667
-19,093
-51% -$552K
SRNE
42
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$433K 0.21%
+51,582
New +$822K
GRUB
43
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$426K 0.21%
8,761
-1,841
-17% -$107K
KYNB
44
Kyntra Bio
KYNB
$27.6M
$390K 0.19%
712
-9,562
-93% -$5.79M
UAM
45
DELISTED
Universal American Corp
UAM
$337K 0.17%
49,315
– –
CORT icon
46
Corcept Therapeutics
CORT
$12.2B
$81K 0.04%
+21,419
New +$109K
TOVX icon
47
Theriva Biologics
TOVX
$9.44M
$54K 0.03%
3
– –
AR icon
48
Antero Resources
AR
$11B
– –
-207,211
Closed -$7.12M
BLUE
49
DELISTED
bluebird bio
BLUE
– –
-4,154
Closed -$9.06M
CHGG icon
50
Chegg
CHGG
$113M
– –
-39,334
Closed -$308K
1
2
3

Similar funds

FFS
Flavin Financial Services Melbourne, Florida $149M AUM 14.79% 1-Year Est. Return
KCM
KM Capital Management Austin, Texas $149M AUM 18.7% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $148M AUM 20.92% 1-Year Est. Return
DAC
Dutch Asset Corp Selkirk, New York $149M AUM
RCM
Rockbridge Capital Management Alexandria, Virginia $149M AUM 1.06% 1-Year Est. Return
AWA
Authentikos Wealth Advisory Morgan Hill, California $148M AUM 9.86% 1-Year Est. Return
JWM
Jacksonville Wealth Management Jacksonville, Florida $148M AUM 23.77% 1-Year Est. Return
AWF
Alpha Wealth Funds Park City, Utah $149M AUM 10.03% 1-Year Est. Return

Hamilton Lane Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Hamilton Lane Advisors held 73 positions worth $203M, down 23% from $265M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Hamilton Lane Advisors withdrew a net $31.6M in Q3 2015, closing 25 positions and reducing 20 holdings. Its most notable exit was bluebird bio, an estimated $9.06M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Hamilton Lane Advisors opened a new position in Palo Alto Networks worth $18.2M.

  • Hamilton Lane Advisors's largest Q3 2015 buy was Palo Alto Networks: 635,544 shares worth $18.2M.
  • Hamilton Lane Advisors added most to Sage Therapeutics in Q3 2015, an estimated $3.28M increase.
  • Hamilton Lane Advisors's biggest Q3 2015 reduction was Meta Platforms (Facebook), cutting an estimated $14.8M.
  • Hamilton Lane Advisors fully exited bluebird bio in Q3 2015, selling an estimated $9.06M.
  • Hamilton Lane Advisors's ten largest holdings make up 66% of its $203M portfolio in Q3 2015.
  • Hamilton Lane Advisors opened 13 new positions and closed 25 in Q3 2015.
  • Hamilton Lane Advisors's portfolio value fell 23% quarter-over-quarter to $203M.

Based on Hamilton Lane Advisors's 13F filing for Q3 2015, filed 19 Oct 2015.